Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High expression of CLEC10A in head and neck squamous cell carcinoma indicates favorable prognosis and high-level immune infiltration status.

Cellular immunology - 1 Feb 2022

Zou Mingyuan, Wu Huina, Zhou Meiling, Xiao Feng, Abudushalamu GuliNazhaer, Yao Yuming, Zhao Fengfeng, Gao Wei, Yan Xuejiao, Fan Xiaobo, Wu Guoqiu

Abstract excerpt

Immunotherapy has emerged as a promising treatment modality for HNSCC. However, only a small proportion of HNSCC patients experience clinical benefits from immunotherapy and identifying molecular markers that can serve as effective prognostic signatures and predictive indicators for immunotherapy response in patients with HNSCC is critical. CLEC10A has attracted attention because of its important role in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Down-Regulation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Head and Neck Neoplasms

Share to Lectins, C-Type

Share to Lymphocytes, Tumor-Infiltrating

Share to Squamous Cell Carcinoma of Head and Neck

Share to Tumor Microenvironment

Source

Identifiers

PMID: 35093731
DOI: 10.1016/j.cellimm.2021.104472

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High expression of CLEC10A in head and neck squamous cell carcinoma indicates favorable prognosis and high-level immune infiltration status.PMID 35093731Read ↗

DKC1 as a Novel and Potential Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma correlating With Immune InfiltratesSemantic proximity Read ↗

CLEC10A is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in lung adenocarcinomaSemantic proximity Read ↗

Comprehensive Analysis of Immune Cell Enrichment In The Tumor Microenvironment of Head And Neck Squamous Cell CarcinomaSemantic proximity Read ↗

Comprehensive analysis of the immune effect of the NAT10 in the Head and Neck Squamous Cell CarcinomaSemantic proximity Read ↗

Identification and Validation of Immune Infiltration Phenotypes in Laryngeal Squamous Cell Carcinoma by Integrative Multi-Omics Analysis.Semantic proximity Read ↗

Identification of key survival genes of the tumor microenvironment and immune infiltration in head and neck squamous cell carcinomaSemantic proximity Read ↗

Identification and characterization of CLEC11A and its derived immune signature in gastric cancerSemantic proximity Read ↗

Identifying Novel Necroptosis-Related lncRNAs: Prognostic & Immunotherapy Insights for Head & Neck CancerSemantic proximity Read ↗

Identification of immunocell infiltrates and effective diagnostic biomarkers in laryngeal carcinomaSemantic proximity Read ↗

Clinical characterization and immune regulation of IL17C in head and neck squamous cell carcinoma through 431 samplesSemantic proximity Read ↗

A Pan-Cancer Analysis Reveals CLEC5A as a Biomarker for Cancer Immunity and PrognosisSemantic proximity Read ↗

PLCXD2 expression relates to the immune microenvironment and prognosis of head and neck squamous cell carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.